Apple’s (NASDAQ: AAPL) latest product launch has prompted fresh adjustments from Wall Street, with major firms revising their outlook on the tech company.
The stock has received mostly bullish commentary despite shares slipping after the Apple 2025 event. As of press time, AAPL traded at $226.79, down more than 3%.
Among the analysts, BofA Securities raised its price target on Apple to $270 from $260 while reiterating a ‘Buy’ rating. Analyst Wamsi Mohan noted that the event delivered expected upgrades across the iPhone, Watch, and AirPods lines.
Key highlights included new health features such as heart rate sensing, hypertension notifications, and sleep score tracking, along with AI-powered tools like live translation. On the hardware side, Apple introduced its new A19 and A19 Pro chips, C1X modem, and expanded neural accelerators designed to bolster on-device artificial intelligence capabilities.
The pricing of the flagship iPhone 17 Pro, which now starts at $1,099 for the 256GB version compared with last year’s $999 for the 128GB model, slightly lifted BofA’s financial estimates.
Apple’s AI potential
Mohan emphasized Apple’s ability to lead in “AI at the edge” through its custom silicon and enhanced GPU integration. Despite shares slipping in the aftermath of the event, the firm noted that Apple’s stock historically rebounded within 30 to 60 days following product launches.
Other Wall Street firms also weighed in. In this case, UBS maintained a ‘Neutral’ rating with a $220 price target, citing the company’s shift from the underperforming “Plus” model to the new “Air” variant in the iPhone 17 lineup.
Wedbush reiterated its ‘Outperform’ rating and a $270 target, pointing to the significant upgrade opportunity among the roughly 315 million iPhone users who have not refreshed their devices in more than four years.
For now, investor attention is on Apple’s ability to capitalize on its newest lineup and AI-driven features, with hopes this will trigger a price rally.
Featured image via Shutterstock
